Common Stock, Shares, Outstanding of Krystal Biotech, Inc. from 31 Dec 2016 to 31 Dec 2025

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
Krystal Biotech, Inc. quarterly Common Stock, Shares, Outstanding in shares history and change rate from 31 Dec 2016 to 31 Dec 2025.
  • Krystal Biotech, Inc. Common Stock, Shares, Outstanding for the quarter ending 31 Dec 2025 was 29,192,000, a 1.4% increase year-over-year.
Source SEC data
View on sec.gov
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Change (%)

Krystal Biotech, Inc. Quarterly Common Stock, Shares, Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 29,192,000 +398,000 +1.4% 31 Dec 2025 10-K 17 Feb 2026 2025 FY
Q3 2025 28,984,000 +227,000 +0.79% 30 Sep 2025 10-Q 03 Nov 2025 2025 Q3
Q2 2025 28,927,000 +218,000 +0.76% 30 Jun 2025 10-Q 04 Aug 2025 2025 Q2
Q1 2025 28,899,000 +371,000 +1.3% 31 Mar 2025 10-Q 06 May 2025 2025 Q1
Q4 2024 28,794,000 +557,000 +2% 31 Dec 2024 10-K 17 Feb 2026 2025 FY
Q3 2024 28,757,000 +562,345 +2% 30 Sep 2024 10-Q 04 Nov 2024 2024 Q3
Q2 2024 28,709,000 +734,084 +2.6% 30 Jun 2024 10-Q 05 Aug 2024 2024 Q2
Q1 2024 28,528,000 +2,731,787 +11% 31 Mar 2024 10-Q 06 May 2024 2024 Q1
Q4 2023 28,237,000 +2,473,257 +9.6% 31 Dec 2023 10-K 19 Feb 2025 2024 FY
Q3 2023 28,194,655 +2,484,991 +9.7% 30 Sep 2023 10-Q 06 Nov 2023 2023 Q3
Q2 2023 27,974,916 +2,310,629 +9% 30 Jun 2023 10-Q 07 Aug 2023 2023 Q1
Q1 2023 25,796,213 31 Mar 2023 10-Q 08 May 2023 2023 Q1
Q4 2022 25,763,743 +555,758 +2.2% 31 Dec 2022 10-K 26 Feb 2024 2023 FY
Q3 2022 25,709,664 +3,471,680 +16% 30 Sep 2022 10-Q 07 Nov 2022 2022 Q3
Q2 2022 25,664,287 +3,459,255 +16% 30 Jun 2022 10-Q 08 Aug 2022 2022 Q2
Q4 2021 25,207,985 +5,493,765 +28% 31 Dec 2021 10-K 27 Feb 2023 2021 FY
Q3 2021 22,237,984 +2,531,114 +13% 30 Sep 2021 10-Q 08 Nov 2021 2021 Q3
Q2 2021 22,205,032 +2,540,973 +13% 30 Jun 2021 10-Q 09 Aug 2021 2021 Q2
Q1 2021 22,204,057 +4,833,493 +28% 31 Mar 2021 10-Q 10 May 2021 2021 Q1
Q4 2020 19,714,220 +2,359,910 +14% 31 Dec 2020 10-K 28 Feb 2022 2021 FY
Q3 2020 19,706,870 +2,399,230 +14% 30 Sep 2020 10-Q 09 Nov 2020 2020 Q3
Q2 2020 19,664,059 +2,718,990 +16% 30 Jun 2020 10-Q 07 Aug 2020 2020 Q2
Q1 2020 17,370,564 +2,926,995 +20% 31 Mar 2020 10-Q 04 May 2020 2020 Q1
Q4 2019 17,354,310 +2,925,394 +20% 31 Dec 2019 10-K 01 Mar 2021 2020 FY
Q3 2019 17,307,640 +6,328,724 +58% 30 Sep 2019 10-Q 04 Nov 2019 2019 Q3
Q2 2019 16,945,069 +6,591,153 +64% 30 Jun 2019 10-Q 05 Aug 2019 2019 Q2
Q1 2019 14,443,569 +4,133,954 +40% 31 Mar 2019 10-Q 07 May 2019 2019 Q1
Q4 2018 14,428,916 +4,121,669 +40% 31 Dec 2018 10-K 10 Mar 2020 2019 FY
Q3 2018 10,978,916 +741,669 +7.2% 30 Sep 2018 10-Q 05 Nov 2018 2018 Q3
Q2 2018 10,353,916 30 Jun 2018 10-Q 06 Aug 2018 2018 Q2
Q1 2018 10,309,615 +6,818,731 +195% 31 Mar 2018 10-Q 07 May 2018 2018 Q1
Q4 2017 10,307,247 +10,307,247 31 Dec 2017 10-Q 05 Nov 2018 2018 Q3
Q3 2017 10,237,247 30 Sep 2017 10-Q 13 Nov 2017 2017 Q3
Q1 2017 3,490,884 31 Mar 2017 10-K 12 Mar 2018 2017 FY
Q4 2016 0 31 Dec 2016 10-K 12 Mar 2018 2017 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.